person · Reporting owner

O'Connor Kevin J.

Disclosed activity across 3 companies

Tapewire entity: 14905
SEC CIK: 0001808321

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CARRIER GLOBAL CorpCARR · Entity 3043	Senior VP & CLO	November 06, 2024	November 08, 2024
Encompass Health CorpEHC · Entity 3460	Director	July 15, 2026	July 16, 2026
LOCKHEED MARTIN CORPLMT · Entity 2882	SVP & General Counsel	February 25, 2026	February 27, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CARRIER GLOBAL Corp

Report date November 06, 2024 · Filed November 08, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	46,083	Ending reported balance After 2024-11-06 transaction · row 4 4 source rows · reconciled sequence Row 1 · 2024-11-06 · Exercise / conversion · Acquired 217,150 · Balance 263,233 F1: The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. Row 2 · 2024-11-06 · Exercise / conversion · Acquired 32,000 · Balance 295,233 F1: The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. Row 3 · 2024-11-06 · Tax withholding · Disposed 81,967 · Balance 213,266 Row 4 · 2024-11-06 · Sale · Disposed 167,183 · Balance 46,083 F2: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $73.00 to $73.93 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $25.60 · Expires 2030-01-01	Direct	0	Reported balance After 2024-11-06 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2024-11-06 · Exercise / conversion · Disposed 217,150 · Balance 0
Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $16.55 · Expires 2030-05-13	Direct	78,200	Reported balance After 2024-11-06 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2024-11-06 · Exercise / conversion · Disposed 32,000 · Balance 78,200

Filing footnotes · ownership attribution and instrument terms

F1: The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

F2: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $73.00 to $73.93 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Encompass Health Corp

Report date July 15, 2026 · Filed July 16, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Encompass Health Common StockSEC Table I · non-derivative	Direct	11,582	Reported balance After 2026-07-15 transaction · row 1 1 source row Row 1 · 2026-07-15 · Grant · Acquired 19 · Balance 11,582 F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

LOCKHEED MARTIN CORP

Report date February 25, 2026 · Filed February 27, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	2,719	Ending reported balance After 2026-02-26 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-02-26 · Exercise / conversion · Acquired 5,285 · Balance 5,285 F1: Each restricted stock unit granted on February 26, 2025, was the economic equivalent of one share of LMT common stock. Row 2 · 2026-02-26 · Tax withholding · Disposed 2,566 · Balance 2,719 F2: Disposition to the Issuer of shares to satisfy the Reporting Person's tax withholding obligation upon vesting and settlement of stock units which is exempt under Rule 16b-3.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2029-02-25	Direct	1,992	Reported balance After 2026-02-25 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-02-25 · Grant · Acquired 1,992 · Balance 1,992 F4: Each restricted stock unit represents a contingent right to receive one share of LMT common stock. F5: Award of restricted stock units which vests on the third anniversary of the grant date.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2028-02-26	Direct	13,289	Reported balance After 2026-02-26 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2026-02-26 · Exercise / conversion · Disposed 5,285 · Balance 13,289 F6: Restricted stock units convert to common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	IndirectLockheed Martin Salaried Savings Plan	36.9851	Reported balance Holding disclosure · report date 2026-02-25 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 36.9851 F3: Holdings as of reportable transaction date include additional acquisitions and dividend reinvestment under the company's 401(k) plan.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit granted on February 26, 2025, was the economic equivalent of one share of LMT common stock.

F2: Disposition to the Issuer of shares to satisfy the Reporting Person's tax withholding obligation upon vesting and settlement of stock units which is exempt under Rule 16b-3.

F3: Holdings as of reportable transaction date include additional acquisitions and dividend reinvestment under the company's 401(k) plan.

F4: Each restricted stock unit represents a contingent right to receive one share of LMT common stock.

F5: Award of restricted stock units which vests on the third anniversary of the grant date.

F6: Restricted stock units convert to common stock on a one-for-one basis.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 15, 2026 Filed Jul 16, 2026 20:15 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	19	$0.00	$0.00	Disclosure SEC source: 0000785161-26-000172 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,582 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment. Read SEC document
May 07, 2026 Filed May 11, 2026 15:46 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	1,634	$0.00	$0.00	Disclosure SEC source: 0000785161-26-000148 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,563 F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document
April 15, 2026 Filed Apr 16, 2026 18:43 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	17	$0.00	$0.00	Disclosure SEC source: 0000785161-26-000115 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,929 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:16 UTC	LOCKHEED MARTIN CORP LMT · Entity 2882	Exercise / conversionRestricted Stock Units · Derivative	5,285	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-26-002767 · doc4.xml · derivative · entry 5 O'Connor Kevin J. · CIK 0001808321 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,289 Underlying: Common Stock · 5,285 shares Expires 2028-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F6 · price: Restricted stock units convert to common stock on a one-for-one basis. F6 · derivative.exercise_date: Restricted stock units convert to common stock on a one-for-one basis. F6 · derivative.expiration_date: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:16 UTC	LOCKHEED MARTIN CORP LMT · Entity 2882	Tax withholdingCommon Stock	2,566	$641.63	$1,646,422.58	Disclosure SEC source: 0001225208-26-002767 · doc4.xml · nonDerivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,719 F2 · shares: Disposition to the Issuer of shares to satisfy the Reporting Person's tax withholding obligation upon vesting and settlement of stock units which is exempt under Rule 16b-3. Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:16 UTC	LOCKHEED MARTIN CORP LMT · Entity 2882	Exercise / conversionCommon Stock	5,285	$0.00	$0.00	Disclosure SEC source: 0001225208-26-002767 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit granted on February 26, 2025, was the economic equivalent of one share of LMT common stock. Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:16 UTC	LOCKHEED MARTIN CORP LMT · Entity 2882	GrantRestricted Stock Units · Derivative	1,992	$0.00	$0.00	Disclosure SEC source: 0001225208-26-002767 · doc4.xml · derivative · entry 4 O'Connor Kevin J. · CIK 0001808321 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,992 Underlying: Common Stock · 1,992 shares Expires 2029-02-25 F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of LMT common stock. F5 · shares: Award of restricted stock units which vests on the third anniversary of the grant date. F5 · derivative.exercise_date: Award of restricted stock units which vests on the third anniversary of the grant date. F5 · derivative.underlying_shares: Award of restricted stock units which vests on the third anniversary of the grant date. Read SEC document
January 15, 2026 Filed Jan 16, 2026 21:23 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	17	$0.00	$0.00	Disclosure SEC source: 0000785161-26-000010 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,912 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
October 15, 2025 Filed Oct 16, 2025 19:39 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	14	$0.00	$0.00	Disclosure SEC source: 0000785161-25-000102 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,895 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2025, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $123.65. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
July 15, 2025 Filed Jul 16, 2025 18:16 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	15	$0.00	$0.00	Disclosure SEC source: 0001127602-25-019253 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,881 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $107.28. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
May 01, 2025 Filed May 2, 2025 18:30 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	1,424	$0.00	$0.00	Disclosure SEC source: 0001127602-25-013126 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,866 F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document
April 15, 2025 Filed Apr 16, 2025 21:00 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	13	$0.00	$0.00	Disclosure SEC source: 0001127602-25-012160 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,442 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $102.30. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
February 26, 2025 Filed Mar 1, 2025 01:01 UTC	LOCKHEED MARTIN CORP LMT · Entity 2882	GrantRestricted Stock Units · Derivative	2,718	$0.00	$0.00	Disclosure SEC source: 0001225208-25-002633 · doc4.xml · derivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,574 Underlying: Common Stock · 2,718 shares Expires 2028-02-26 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of LMT common stock. F3 · shares: Award of restricted stock units which vests on the third anniversary of the grant date. F3 · derivative.exercise_date: Award of restricted stock units which vests on the third anniversary of the grant date. F3 · derivative.underlying_shares: Award of restricted stock units which vests on the third anniversary of the grant date. Read SEC document
February 26, 2025 Filed Mar 1, 2025 01:01 UTC	LOCKHEED MARTIN CORP LMT · Entity 2882	GrantRestricted Stock Units · Derivative	15,856	$0.00	$0.00	Disclosure SEC source: 0001225208-25-002633 · doc4.xml · derivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,856 Underlying: Common Stock · 15,856 shares Expires 2028-02-26 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of LMT common stock. F2 · shares: Represents the one-time award of restricted stock units to compensate the Reporting Person for the forfeiture of incentive awards at his former employer. The restricted stock units vest in three equal annual installments commencing on the first anniversary of the grant date. F2 · derivative.exercise_date: Represents the one-time award of restricted stock units to compensate the Reporting Person for the forfeiture of incentive awards at his former employer. The restricted stock units vest in three equal annual installments commencing on the first anniversary of the grant date. F2 · derivative.underlying_shares: Represents the one-time award of restricted stock units to compensate the Reporting Person for the forfeiture of incentive awards at his former employer. The restricted stock units vest in three equal annual installments commencing on the first anniversary of the grant date. Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:52 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	14	$0.00	$0.00	Disclosure SEC source: 0001127602-25-001413 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,429 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $93.61. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:53 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionStock Appreciation Right · Derivative	32,000	$74.28 Strike: $16.55	$2,376,960.00	Disclosure SEC source: 0001225208-24-009822 · doc4.xml · derivative · entry 6 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,200 Underlying: Common Stock · 32,000 shares Expires 2030-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:53 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionStock Appreciation Right · Derivative	217,150	$74.28 Strike: $25.60	$16,129,902.00	Disclosure SEC source: 0001225208-24-009822 · doc4.xml · derivative · entry 5 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 217,150 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:53 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	SaleCommon Stock	167,183	$73.46	$12,281,697.86	Disclosure SEC source: 0001225208-24-009822 · doc4.xml · nonDerivative · entry 4 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,083 F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $73.00 to $73.93 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:53 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Tax withholdingCommon Stock	81,967	$74.28	$6,088,508.76	Disclosure SEC source: 0001225208-24-009822 · doc4.xml · nonDerivative · entry 3 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,266 Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:53 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionCommon Stock	32,000	$16.55	$529,600.00	Disclosure SEC source: 0001225208-24-009822 · doc4.xml · nonDerivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:53 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionCommon Stock	217,150	$25.60	$5,559,040.00	Disclosure SEC source: 0001225208-24-009822 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Stock Appreciation Rights (SARs) were settled in shares in accordance with terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARS and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share. Read SEC document
October 15, 2024 Filed Oct 17, 2024 17:14 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	14	$0.00	$0.00	Disclosure SEC source: 0001127602-24-025664 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,415 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2024, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $96.33. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
July 15, 2024 Filed Jul 17, 2024 20:10 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	13	$0.00	$0.00	Disclosure SEC source: 0001127602-24-020562 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,401 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $85.49. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
May 16, 2024 Filed May 17, 2024 20:04 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	SaleCommon Stock	20,000	$65.73	$1,314,624.00	Disclosure SEC source: 0001225208-24-006177 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,083 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $65.46 to $65.93 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document
May 02, 2024 Filed May 3, 2024 17:13 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	1,978	$0.00	$0.00	Disclosure SEC source: 0001127602-24-014076 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,388 F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document
April 15, 2024 Filed Apr 16, 2024 20:57 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	11	$0.00	$0.00	Disclosure SEC source: 0001127602-24-013015 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,410 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $80.73. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
February 08, 2024 Filed Feb 9, 2024 21:26 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	SaleCommon Stock	26,551	$53.77	$1,427,676.48	Disclosure SEC source: 0001225208-24-001804 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,083 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $53.58 to $53.935 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document
February 04, 2024 Filed Feb 6, 2024 21:36 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Tax withholdingCommon Stock	13,285	$56.78	$754,322.30	Disclosure SEC source: 0001225208-24-001640 · doc4.xml · nonDerivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,634 Read SEC document
February 04, 2024 Filed Feb 6, 2024 21:36 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	GrantCommon Stock	39,836	$0.00	$0.00	Disclosure SEC source: 0001225208-24-001640 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,919 F1 · date: The acquistion of shares of Carrier common stock represents the vesting of performance share units (PSUs) previously awarded on February 4, 2021 to the reporting person under the Carrier Global Corporation 2020 Long-Term Incentive Plan. Each PSU has a value equal to one share of Carrier Global Corporation common stock. These PSUs vested upon the achievement of the pre-established performance targets for earnings per share growth and total shareholder return relative to a subset of industrial companies in the S&P 500 index over a three-year time period. The performance criteria were satisfied at the 185.5% level. Read SEC document
January 30, 2024 Filed Feb 1, 2024 21:34 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	GrantStock Appreciation Right · Derivative	67,635	$0.00 Strike: $56.33	$0.00	Disclosure SEC source: 0001225208-24-001377 · doc4.xml · derivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,635 Underlying: Common Stock · 67,635 shares Expires 2034-01-29 F1 · balance_after: The reporting person was also awarded 17,490 Performance Share Units (PSUs) under the Carrier Global Corporation 2020 Long-Term Incentive Plan. Each PSU represents a contingent right to receive one share of Carrier Global Corporation common stock. The PSUs vest on the third anniversary of the grant date contingent upon (a) the reporting person's continued employment and (b) Carrier's achievement of pre-established performance targets for earnings per share growth and total shareowner return relative to a subset of industrial companies in the S&P 500 index over a three-year time period. Read SEC document
January 16, 2024 Filed Jan 17, 2024 20:31 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	12	$0.00	$0.00	Disclosure SEC source: 0001127602-24-001401 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,399 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $71.45. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
October 16, 2023 Filed Oct 17, 2023 21:22 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	13	$0.00	$0.00	Disclosure SEC source: 0001127602-23-026019 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,387 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $63.77. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
July 17, 2023 Filed Jul 18, 2023 17:58 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	12	$0.00	$0.00	Disclosure SEC source: 0001127602-23-020913 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,374 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $67.54. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
May 26, 2023 Filed May 26, 2023 20:07 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	SaleCommon Stock	21,049	$41.13	$865,688.54	Disclosure SEC source: 0001225208-23-006240 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,083 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $40.9400 to $41.4050 per share. The reporting person has provided to the issuer and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document
May 16, 2023 Filed May 17, 2023 20:16 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Tax withholdingCommon Stock	24,264	$42.15	$1,022,727.60	Disclosure SEC source: 0001225208-23-006003 · doc4.xml · nonDerivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,132 Read SEC document
May 16, 2023 Filed May 17, 2023 20:16 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	GrantCommon Stock	61,660	$0.00	$0.00	Disclosure SEC source: 0001225208-23-006003 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,396 F1 · date: The acquisition of shares of Carrier common stock represents the vesting of performance share units (PSUs) previously awarded on May 14, 2020 as part of a founder's grant awarded to the reporting person under the Carrier Global Corporation 2020 Long-Term Incentive Plan. Each PSU has a value equal to one share of Carrier Global Corporation common stock. These PSUs vested solely upon achievement of the pre-established performance target for Carrier's total shareholder return relative to a subset of industrial companies in the S&P 500 index over a three-year time period. The performance criteria was satisfied at the 200% level. Read SEC document
May 04, 2023 Filed May 8, 2023 17:07 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	2,385	$0.00	$0.00	Disclosure SEC source: 0001127602-23-014817 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,362 F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document
April 17, 2023 Filed Apr 19, 2023 17:20 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	8	$0.00	$0.00	Disclosure SEC source: 0001127602-23-013210 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,977 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:10 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionRestricted Stock Unit RSU · Derivative	143	$0.00	$0.00	Disclosure SEC source: 0001225208-23-001884 · doc4.xml · derivative · entry 6 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 143 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of Carrier Global Corporation common stock. The RSUs vest contingent upon the reporting person's continued employment at the conclusion of the vesting period. F3 · derivative.exercise_date: The reporting person was granted RSUs on February 4, 2020 by United Technologies Corporation (UTC), the former parent of the issuer. These RSUs were converted into RSUs of the issuer in connection with the spin-off of the issuer by UTC. And on February 7, 2023, the reporting person reported that the previously awarded RSUs, including dividend equivalents, vested and converted to Carrier common stock. Those previously awarded RSUs were entitled to additional dividend equivalents that were not payable until February 10, 2023. F3 · derivative.expiration_date: The reporting person was granted RSUs on February 4, 2020 by United Technologies Corporation (UTC), the former parent of the issuer. These RSUs were converted into RSUs of the issuer in connection with the spin-off of the issuer by UTC. And on February 7, 2023, the reporting person reported that the previously awarded RSUs, including dividend equivalents, vested and converted to Carrier common stock. Those previously awarded RSUs were entitled to additional dividend equivalents that were not payable until February 10, 2023. Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:10 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionRestricted Stock Unit RSU · Derivative	167	$0.00	$0.00	Disclosure SEC source: 0001225208-23-001884 · doc4.xml · derivative · entry 5 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of Carrier Global Corporation common stock. The RSUs vest contingent upon the reporting person's continued employment at the conclusion of the vesting period. F2 · derivative.exercise_date: The reporting person was granted RSUs on January 2, 2020 by United Technologies Corporation (UTC), the former parent of the issuer. These RSUs were converted into RSUs of the issuer in connection with the spin-off of the issuer by UTC. And on January 3, 2023, the reporting person reported that the previously awarded RSUs, including dividend equivalents, vested and converted to Carrier common stock. Those previously awarded RSUs were entitled to additional dividend equivalents that were not payable until February 10, 2023. F2 · derivative.expiration_date: The reporting person was granted RSUs on January 2, 2020 by United Technologies Corporation (UTC), the former parent of the issuer. These RSUs were converted into RSUs of the issuer in connection with the spin-off of the issuer by UTC. And on January 3, 2023, the reporting person reported that the previously awarded RSUs, including dividend equivalents, vested and converted to Carrier common stock. Those previously awarded RSUs were entitled to additional dividend equivalents that were not payable until February 10, 2023. Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:10 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Tax withholdingCommon Stock	66	$44.83	$2,958.78	Disclosure SEC source: 0001225208-23-001884 · doc4.xml · nonDerivative · entry 4 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,344 Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:10 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Tax withholdingCommon Stock	57	$44.83	$2,555.31	Disclosure SEC source: 0001225208-23-001884 · doc4.xml · nonDerivative · entry 3 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,410 Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:10 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionCommon Stock	143	$0.00	$0.00	Disclosure SEC source: 0001225208-23-001884 · doc4.xml · nonDerivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of Carrier Global Corporation common stock. The RSUs vest contingent upon the reporting person's continued employment at the conclusion of the vesting period. Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:10 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionCommon Stock	167	$0.00	$0.00	Disclosure SEC source: 0001225208-23-001884 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of Carrier Global Corporation common stock. The RSUs vest contingent upon the reporting person's continued employment at the conclusion of the vesting period. Read SEC document
February 04, 2023 Filed Feb 7, 2023 21:11 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionRestricted Stock Unit RSU · Derivative	34,706	$0.00	$0.00	Disclosure SEC source: 0001225208-23-001420 · doc4.xml · derivative · entry 3 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,706 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of Carrier Global Corporation common stock. The RSUs vest contingent upon the reporting person's continued employment at the conclusion of the vesting period. F2 · derivative.exercise_date: The reporting person was originally granted RSUs on February 4, 2020 by United Technologies Corporation (UTC), the former parent company of the Issuer. These RSUs were converted into RSUs of the Issuer in connection with the spin-off of the Issuer by UTC. F2 · derivative.expiration_date: The reporting person was originally granted RSUs on February 4, 2020 by United Technologies Corporation (UTC), the former parent company of the Issuer. These RSUs were converted into RSUs of the Issuer in connection with the spin-off of the Issuer by UTC. Read SEC document
February 04, 2023 Filed Feb 7, 2023 21:11 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Tax withholdingCommon Stock	21,049	$46.89	$986,987.61	Disclosure SEC source: 0001225208-23-001420 · doc4.xml · nonDerivative · entry 2 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,157 Read SEC document
February 04, 2023 Filed Feb 7, 2023 21:11 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	Exercise / conversionCommon Stock	34,706	$0.00	$0.00	Disclosure SEC source: 0001225208-23-001420 · doc4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of Carrier Global Corporation common stock. The RSUs vest contingent upon the reporting person's continued employment at the conclusion of the vesting period. Read SEC document
February 04, 2023 Filed Feb 24, 2023 21:09 UTC Amendment	CARRIER GLOBAL Corp CARR · Entity 3043	Tax withholdingCommon Stock	13,657	$46.89	$640,376.73	Disclosure SEC source: 0001225208-23-002778 · doc4a.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,549 F1 · balance_after: On February 7, 2023, the reporting person filed a Form 4 that inadvertently incorrectly reported 21,049 shares withheld for the payment of taxes. The correct number of shares withheld was 13,657. On February 14, 2023, the reporting person filed a Form 4 that inadvertently incorrectly reported the amount of securities beneficially owned following the reported transactions as a result of the prior error corrected by this filing. Read SEC document
February 01, 2023 Filed Feb 3, 2023 23:23 UTC	CARRIER GLOBAL Corp CARR · Entity 3043	GrantStock Appreciation Right · Derivative	77,205	$0.00 Strike: $46.14	$0.00	Disclosure SEC source: 0001225208-23-001313 · doc4.xml · derivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Senior VP & CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,205 Underlying: Common Stock · 77,205 shares Expires 2033-01-31 F1 · balance_after: The reporting person was also awarded 19,490 Performance Share Units (PSUs) under the Carrier Global Corporation 2020 Long-Term Incentive Plan. Each PSU represents a contingent right to receive one share of Carrier Global Corporation common stock. The PSUs vest on the third anniversary of the grant date contingent upon (a) the reporting person's continued employment and (b) Carrier's achievement of pre-established performance targets for earnings per share growth and total shareowner return relative to a subset of industrial companies in the S&P 500 index over a three-year time period. Read SEC document
January 17, 2023 Filed Jan 19, 2023 16:41 UTC	Encompass Health Corp EHC · Entity 3460	GrantEncompass Health Common Stock	8	$0.00	$0.00	Disclosure SEC source: 0001127602-23-001741 · form4.xml · nonDerivative · entry 1 O'Connor Kevin J. · CIK 0001808321 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,969 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.16. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.